← Eichor
Condition: Target Organ Damage Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Target Organ Damage

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Effect of Treatment With Finerenone on Cardio-Renal Target Organ Damage in Patients With Type 2 Diabetes.
Phase 4 · 1 location(s) · University of Aarhus · NCT07026539Glycoxidation, Arterial Biomechanics, and Target Organ Damage
Phase N/A · 1 location(s) · Complejo Hospitalario Universitario de Santiago · NCT06325800Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE)
Phase N/A · 1 location(s) · Wake Forest University Health Sciences · NCT04752293
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.